ENGNW
enGene Holdings Inc. Warrants
NASDAQ · Healthcare · Biotechnology · CA
$0.21
−4.55%Next report
Analyst consensus
- Next report date
- Sep 16, 2026
- EPS estimate
- -$0.43
- Revenue estimate
- —
Latest reported
- Last report date
- Jun 15, 2026
- EPS actual
- -$0.43
- EPS estimate
- -$0.47
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +244.7%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 16, 2026